DK0580596T3 - Gen muteret i colorektal cancer hos mennesker - Google Patents

Gen muteret i colorektal cancer hos mennesker

Info

Publication number
DK0580596T3
DK0580596T3 DK92905276T DK92905276T DK0580596T3 DK 0580596 T3 DK0580596 T3 DK 0580596T3 DK 92905276 T DK92905276 T DK 92905276T DK 92905276 T DK92905276 T DK 92905276T DK 0580596 T3 DK0580596 T3 DK 0580596T3
Authority
DK
Denmark
Prior art keywords
mcc
humans
colorectal cancer
gene
gene mutated
Prior art date
Application number
DK92905276T
Other languages
English (en)
Inventor
Yusuke Nakamura
Bert Vogelstein
Kenneth W Kinzler
Raymond L White
Original Assignee
Univ Johns Hopkins
Univ Utah
Japan Found Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins, Univ Utah, Japan Found Cancer filed Critical Univ Johns Hopkins
Application granted granted Critical
Publication of DK0580596T3 publication Critical patent/DK0580596T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92905276T 1991-03-13 1992-01-16 Gen muteret i colorektal cancer hos mennesker DK0580596T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/670,611 US5330892A (en) 1991-03-13 1991-03-13 MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans
PCT/US1992/000377 WO1992016656A1 (en) 1991-03-13 1992-01-16 Gene mutated in colorectal cancer of humans

Publications (1)

Publication Number Publication Date
DK0580596T3 true DK0580596T3 (da) 2000-10-30

Family

ID=24691103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92905276T DK0580596T3 (da) 1991-03-13 1992-01-16 Gen muteret i colorektal cancer hos mennesker

Country Status (11)

Country Link
US (5) US5330892A (da)
EP (1) EP0580596B1 (da)
JP (1) JP3501802B2 (da)
AT (1) ATE194660T1 (da)
AU (1) AU664834B2 (da)
CA (1) CA2105876A1 (da)
DE (1) DE69231245T2 (da)
DK (1) DK0580596T3 (da)
ES (1) ES2148171T3 (da)
GR (1) GR3034446T3 (da)
WO (1) WO1992016656A1 (da)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330892A (en) * 1991-03-13 1994-07-19 The Johns Hopkins University MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans
WO1993020235A1 (en) 1992-04-01 1993-10-14 The Johns Hopkins University School Of Medicine Methods of detecting mammalian nucleic acids isolated from stool specimen and reagents therefor
US7326778B1 (en) * 1993-05-05 2008-02-05 The John Hopkins University Mutator gene and hereditary non-polyposis colorectal cancer
CA2163422A1 (en) * 1993-05-26 1994-12-08 Arthur Bruskin Antibodies specific for dcc gene product
US7097839B1 (en) 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US5962220A (en) * 1993-10-26 1999-10-05 Thomas Jefferson University Compositions that specifically bind to colorectal cells and methods of using the same
DE4431174A1 (de) * 1994-09-01 1996-03-07 Deutsches Krebsforsch Nachweisverfahren für tumorspezifische mRNA
US5891629A (en) * 1995-09-28 1999-04-06 Ambion, Inc. Compositions for improving RNase cleavage of base pair mismatches in double-stranded nucleic acids
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US6242212B1 (en) * 1996-02-09 2001-06-05 Thomas Jefferson University Fragile histidine triad (FHIT) nucleic acids and methods of producing FHIT proteins
US5858673A (en) * 1996-06-24 1999-01-12 Charlotte-Mecklenburg Hospital Authority Method for detecting prostate cells
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US5952178A (en) 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6406857B1 (en) 1997-06-16 2002-06-18 Exact Sciences Corporation Methods for stool sample preparation
US6268136B1 (en) 1997-06-16 2001-07-31 Exact Science Corporation Methods for stool sample preparation
US7135333B1 (en) 1997-08-07 2006-11-14 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US6120995A (en) * 1997-08-07 2000-09-19 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US20020064792A1 (en) * 1997-11-13 2002-05-30 Lincoln Stephen E. Database for storage and analysis of full-length sequences
US6897018B1 (en) 1998-02-25 2005-05-24 The United States Of America As Represented By The Department Of Health And Human Services DLC-1 gene deleted in cancers
US7226731B1 (en) 1998-07-24 2007-06-05 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services PB 39, a gene dysregulated in prostate cancer, and uses thereof
WO2000005376A1 (en) * 1998-07-24 2000-02-03 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Pb 39, a gene dysregulated in prostate cancer, and uses thereof
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
US6503718B2 (en) 1999-01-10 2003-01-07 Exact Sciences Corporation Methods for detecting mutations using primer extension for detecting disease
ES2269102T3 (es) 1999-02-25 2007-04-01 Exact Sciences Corporation Procedimientos para conservar la integridad del adn.
US6964846B1 (en) * 1999-04-09 2005-11-15 Exact Sciences Corporation Methods for detecting nucleic acids indicative of cancer
US6586177B1 (en) * 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
US6919174B1 (en) * 1999-12-07 2005-07-19 Exact Sciences Corporation Methods for disease detection
AU4714201A (en) * 1999-12-07 2001-06-18 Exact Sciences Corporation Supracolonic aerodigestive neoplasm detection
ATE469242T1 (de) * 2000-03-27 2010-06-15 Univ Jefferson Zusammensetzungen und methoden zur identifizierung und zum targeting von krebszellen aus dem verdauungskanal
EP1312673A4 (en) * 2000-08-25 2004-08-04 Fujirebio Kk PROCESS FOR PROTECTING PERSONAL INFORMATION
US6428964B1 (en) 2001-03-15 2002-08-06 Exact Sciences Corporation Method for alteration detection
WO2003071252A2 (en) * 2002-02-15 2003-08-28 Exact Sciences Corporation Methods for analysis of molecular events
US20040259101A1 (en) * 2003-06-20 2004-12-23 Shuber Anthony P. Methods for disease screening
CA2586515A1 (en) * 2003-11-05 2005-05-26 Exact Sciences Corporation Repetitive reversed-field affinity electrophoresis and uses therefor
CA2553540A1 (en) * 2004-01-23 2005-08-04 Garvan Institute Of Medical Research Methods of diagnosing colorectal cancer and reagents therefor
US20080241827A1 (en) * 2004-05-10 2008-10-02 Exact Sciences Corporation Methods For Detecting A Mutant Nucleic Acid
WO2005113769A1 (en) * 2004-05-14 2005-12-01 Exact Sciences Corporation Method for stabilizing biological samples for nucleic acid analysis
WO2006026654A2 (en) * 2004-08-27 2006-03-09 Exact Sciences Corporation Method for detecting a recombinant event
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
US9777314B2 (en) * 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
US11286519B2 (en) 2013-12-11 2022-03-29 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
US11859246B2 (en) 2013-12-11 2024-01-02 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
CN109706222A (zh) 2013-12-11 2019-05-03 安可济控股有限公司 用于检测罕见序列变体的组合物和方法
CN114807323A (zh) 2015-10-09 2022-07-29 安可济控股有限公司 用于富集扩增产物的方法及组合物
CA3024630A1 (en) 2016-05-16 2017-11-23 Accuragen Holdings Limited Method of improved sequencing by strand identification
SG10202111825YA (en) 2016-08-15 2021-12-30 Accuragen Holdings Ltd Compositions and methods for detecting rare sequence variants
US11203782B2 (en) 2018-03-29 2021-12-21 Accuragen Holdings Limited Compositions and methods comprising asymmetric barcoding
CN115963268B (zh) * 2023-02-14 2023-09-19 浙江大学 一种用于结直肠癌早期诊断的血浆分泌蛋白组合及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625169B2 (en) * 1987-03-23 1992-07-02 Imperial Chemical Industries Plc Molecular markers
DE68928491T2 (de) * 1988-10-31 1998-06-04 Univ California Erzeugnisse und verfahren zur regelung der suppression von neoplastischen phenotypen
US5352775A (en) * 1991-01-16 1994-10-04 The Johns Hopkins Univ. APC gene and nucleic acid probes derived therefrom
US5330892A (en) * 1991-03-13 1994-07-19 The Johns Hopkins University MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans
US5411860A (en) * 1992-04-07 1995-05-02 The Johns Hopkins University Amplification of human MDM2 gene in human tumors

Also Published As

Publication number Publication date
AU664834B2 (en) 1995-12-07
JPH06509701A (ja) 1994-11-02
JP3501802B2 (ja) 2004-03-02
US5693536A (en) 1997-12-02
ES2148171T3 (es) 2000-10-16
US5330892A (en) 1994-07-19
AU1330292A (en) 1992-10-21
CA2105876A1 (en) 1992-09-14
US5576422A (en) 1996-11-19
US5571905A (en) 1996-11-05
EP0580596A1 (en) 1994-02-02
US5830676A (en) 1998-11-03
EP0580596B1 (en) 2000-07-12
DE69231245D1 (de) 2000-08-17
WO1992016656A1 (en) 1992-10-01
DE69231245T2 (de) 2001-02-01
ATE194660T1 (de) 2000-07-15
GR3034446T3 (en) 2000-12-29

Similar Documents

Publication Publication Date Title
DK0580596T3 (da) Gen muteret i colorektal cancer hos mennesker
DK0569527T3 (da) Nedarvede og somatiske mutationer af APC-gen i colorektal cancer hos mennesker
DE69907156D1 (de) Krebsbehandlung
EP0772456A4 (en) DIAGNOSIS AND TREATMENT OF CELL PROLIFERATION DISEASES IN WHICH CLONAL MACROPHAGES ARE INVOLVED
EP0390323A3 (en) Detection of loss of the wild-type p53 gene
DK0507852T3 (da) Gen deleteret hos mennesker med kolorektal cancer
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
CY1110029T1 (el) Γονιδιο που εκφραζεται στον καρκινο του προστατη
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
WO2001025272A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
ES2157994T3 (es) Inhibidores tetra y pentapeptidos sustituidos de la proteina farnesiltransferasa.
EP1767636A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
DE60032784D1 (de) Markerproteine für prostatakrebs
WO2003070889A3 (en) Prostate specific genes and the use thereof in design or therapeutics
ATE143808T1 (de) Proteintyrosinphosphatase alpha - inhibitoren zur tumorbehandlung
ATE323176T1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
Vazquez-Mazariego et al. Cytogenetic study of neuroendocrine carcinoma of Merkel cells
DE69839846D1 (de) Bestimmung der vorhandenen mengen an cyclin-abhängr bei krebspatienten
DE68911305T2 (de) Das lungenwachstum stimulierende und hemmende faktoren für krebstumorzellen.
CY1113516T1 (el) Νουκλεϊκο οξυ και αντιστοιχη πρωτεϊνη με ονομασια 158p1d7 χρησιμα στην αγωγη και ανιχνευση καρκινου ουροδοχου κυστης και αλλων καρκινων
TR200200691T2 (tr) Akciğer kanserinin tedavisine ve teşhisine ilişkin bileşimler
Freer GP contract: the slippery slope